文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

影响4A/4B期早产儿视网膜病变术后成功的因素

Parameters affecting postoperative success of surgery for stage 4A/4B ROP.
PubMed 文献 · Br J Ophthalmol · 2019-01-18

结果显示4A期解剖和功能成功率高于4B期,术前治疗、保留晶状体及手术诱导后玻璃体脱离与更好结果相关,而plus病变、术前未治疗、医源性视网膜裂孔和术后玻璃体出血与较差结果相关。

要点

  • 4A期解剖成功率高于4B期,且随时间保持稳定。
  • 术前激光/抗VEGF治疗、保留晶状体及手术诱导后玻璃体脱离与更好预后相关。
  • plus病变、术前未治疗、医源性视网膜裂孔和术后玻璃体出血与较差预后相关。

核心结论

  • 4期ROP相关视网膜脱离手术可获得较好的解剖和功能结果,术前治疗、保留晶状体手术及手术诱导后玻璃体脱离者结果更佳。

主要发现

  • 4A期解剖成功率第一年86.5%、第二年91.7%、第三年95.8%,4B期分别为68.1%、69.4%、57.9%。
  • 4A期功能成功率第一年85.1%、第二年89.6%、第三年87.5%,4B期分别为65.9%、61.1%、57.8%。
  • 3年随访时平均视力4A期为1.12±0.34 logMAR,4B期为1.34±0.32 logMAR(p>0.05)。
  • 59.5%的眼有术前plus病变,17.4%的眼需再次视网膜手术。

关键数值与推荐

  • 解剖成功和功能成功分别按4A/4B期及术后1、2、3年报告。
  • 术前plus病变、术前未治疗、医源性视网膜裂孔和术后玻璃体出血对结果有显著负面影响。
  • 手术诱导后玻璃体脱离和保留晶状体对解剖和功能结果有正面影响。

临床怎么用

  • 对4A/4B期ROP相关视网膜脱离,优先考虑保留晶状体玻璃体切除术并手术诱导后玻璃体脱离。
  • 术前应积极行激光或抗VEGF治疗,并重视plus病变、医源性裂孔和术后玻璃体出血的风险管理。

局限性

  • 回顾性单中心设计,样本量有限,随访时间不等,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the long-term anatomical and functional results of surgery for retinal detachment (RD) associated with stage 4 retinopathy of prematurity (ROP) and patient and surgery-related factors affecting postoperative success. DESIGN: Retrospective case series at a single tertiary referral paediatric vitreoretinal practice. METHODS: One hundred and twenty-one eyes of 82 infants (40 female/42 male) who underwent lens-sparing vitrectomy (LSV) or lensectomy with vitrectomy surgery for stage 4A and 4B ROP at Gazi University Department of Ophthalmology between 2011 and 2016 were enrolled in this study. Patient characteristics including gestational age, birth weight, gender, stage of ROP at presentation, preoperative treatment (laser, anti-vascular endothelial growth factor (VEGF) or combined), anatomical and functional outcome and complications were recorded. The effect of birth weight, gestational age, presence of plus disease, preoperative treatment status, surgically induced posterior hyaloid detachment, postoperative vitreous haemorrhage and iatrogenic retinal tear formation on anatomical and functional results was evaluated. RESULTS: 61.2% of the eyes were stage 4A and 38.8% were stage 4B ROP. The mean follow-up was 24.5 months. 18.2% of the eyes had no preoperative treatment. Anatomical success was 86.5% for stage 4A and 68.1% for stage 4B at the first year, 91.7% for stage 4A and 69.4% for stage 4B at the second year, and 95.8% for stage 4A and 57.9% for stage 4B at the third year. Functional success was 85.1% for stage 4A and 65.9% for stage 4B at the first year, 89.6% for stage 4A and 61.1% for stage 4B at the second year, and 87.5% for stage 4A and 57.8% for stage 4B at the third year. The mean visual acuity was 1.12±0.34 logarithm of the minimum angle of resolution (logMAR) for stage 4A and 1.34±0.32 logMAR at the 3-year follow-up duration (p>0.05). There was preoperative plus disease in 59.5% of the eyes. Subsequent retinal surgeries were required in 17.4% of the eyes. Presence of plus disease and absence of preoperative treatment, iatrogenic retinal tear formation and postoperative vitreous haemorrhage were found to have significant negative effects, while surgical induction of posterior hyaloid detachment and sparing the lens intraoperatively affected the anatomical and functional results positively. CONCLUSIONS: Surgery for stage 4 ROP-associated RD resulted in encouraging anatomical and functional outcomes and the results are even better in eyes with preoperative (laser/anti-VEGF) treatment, LSV and surgically induced posterior hyaloid detachment.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Özsaygili C, Ozdek S, Ozmen MC, et al. Parameters affecting postoperative success of surgery for stage 4A/4B ROP. Br J Ophthalmol. 2019. PMID: 30658990. doi:10.1136/bjophthalmol-2018-312922

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。